📰 Abt News
Page 8 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
May 5, 2024
Axxcess Wealth Management LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 10.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 107,473 shares of the healthcare product maker’s stock after buying an additional 9,763 shares during […]
May 5, 2024
ARS Wealth Advisors Group LLC grew its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 21.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,002 shares of the healthcare product maker’s stock after purchasing an additional 876 shares during […]
May 4, 2024
Arcblock (ABT) traded 15.2% higher against the dollar during the one day period ending at 22:00 PM Eastern on May 3rd. One Arcblock token can now be bought for about $3.40 or 0.00005399 BTC on popular cryptocurrency exchanges. Arcblock has a market capitalization of $335.06 million and $27.95 million worth of Arcblock was traded on […]
May 4, 2024
Victory Capital Management Inc. lifted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 6.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 665,391 shares of the healthcare product maker’s stock after acquiring an additional 40,702 shares during the […]
May 4, 2024
U.S. Capital Wealth Advisors LLC raised its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 69.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 32,729 shares of the healthcare product maker’s stock after acquiring an additional 13,461 shares during the period. U.S. Capital Wealth Advisors LLC’s holdings in Abbott Laboratories were worth […]
May 3, 2024
Swiss National Bank trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,426,480 shares of the healthcare product maker’s stock after selling 166,800 shares during the period. Swiss […]
May 3, 2024
Benjamin F. Edwards & Company Inc. raised its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 265.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 235,551 shares of the healthcare product maker’s stock after buying an additional 171,077 shares during the period. Benjamin […]
May 2, 2024
One Day In July LLC cut its position in Abbott Laboratories (NYSE:ABT – Free Report) by 13.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,423 shares of the healthcare product maker’s stock after selling 380 shares during the quarter. One Day In July […]
May 2, 2024
Riverpoint Wealth Management Holdings LLC acquired a new position in Abbott Laboratories (NYSE:ABT – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,954 shares of the healthcare product maker’s stock, valued at approximately $215,000. A number of […]
May 2, 2024
FFT Wealth Management LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 9.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,711 shares of the healthcare product maker’s stock after buying an additional 231 shares during the […]